Investor Relations

Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT™, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Recent News

September 30, 2014
Pacific Biosciences of California, Inc. Third Quarter 2014 Financial Results Call

MENLO PARK, Calif., Sept. 30, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss its Third Quarter 2014 Financial Results...

September 23, 2014
Macrogen Selects Single Molecule, Real-Time Sequencing for High-Quality de Novo Asian Human Reference Genomes

MENLO PARK, Calif. and SEOUL, Korea, Sept. 23, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II DNA Sequencing System, and Macrogen, a...

Events & Presentations

Oct 23, 2014 at 4:30 PM ET
Pacific Biosciences of California, Inc. Third Quarter 2014 Earnings Conference Call
Dec 2, 2014
The 26th Annual Piper Jaffray Healthcare Conference

Stock Quote

Last Trade
3:59 PM ET
Oct 1, 2014
Change (%)
52 Week High
52 Week Low
Day High
Day Low


Pacific Biosciences

1380 Willow Rd.
Menlo Park, CA 94025
(650) 521-8450

Supernav grey background

Supernav grey background

Super Navigation block